Detailed text transcripts for TV channel - FOXNEWS - 20170825:11:45:00
Previously treated withd platinum-based chemotherapy, including those with an abnormal alk or egfr gene whove tried an fda-approved targeted therapy, heres a question: who wouldnt want a chance for another...? whod say no to a...? who wouldnt want... a chance to live longer. opdivo (nivolumab). opdivo demonstrated longer life versus chemotherapy. over 40,000 of these patients have been prescribed opdivo. opdivo works with your immune system. opdivo can cause your immune system to attack normal o...
Source: news source